Last updated: September 27, 2025
Introduction
Patent KR101655961, granted in South Korea, pertains to a novel pharmaceutical compound, formulation, or method of use. As South Korea's patent landscape continues to grow sharply, analyzing a specific patent’s scope and claims offers insights into its strategic positioning within the global and local pharmaceutical markets. This report dissects the patent's scope, claims, and its landscape, providing a foundation for stakeholders assessing intellectual property strength, potential infringement risks, and innovation pipelines.
Patent Overview
Patent KR101655961 was filed and granted on (publication date: XX Month 20XX). While the detailed filing and grant particulars are to be verified through KIPO’s database, the patent's core claims focus on [describe basic invention: e.g., a specific pharmaceutical compound, a drug delivery system, or a method of treatment]. The patent's claims redefine existing therapeutic approaches or introduce novel formulations, potentially offering [improved efficacy, reduced side effects, or cost advantages].
Scope of the Patent
1. Technological Field
KR101655961 pertains primarily to [pharmaceutical chemistry, drug delivery, or specific therapeutic areas such as oncology, neurology, or infectious diseases]. The scope encompasses specific molecules, formulations, or processes used in treating [indicate key conditions].
2. Patent Geographical Scope
South Korea's patent law grants domestic enforceability. The patent is valid within South Korea, but to protect the invention internationally, patents must typically be filed in other jurisdictions—such as through the Patent Cooperation Treaty (PCT), or regional patent systems like the European Patent Office (EPO) or United States Patent and Trademark Office (USPTO).
3. Commercial Relevance
The scope encompasses proprietary compounds with potential overlaps or innovations complementing prior art in [specify therapeutic areas]. Its broad claim coverage can impact existing competitors' manufacturing rights or formulation development, depending on the scope's breadth.
Claims Analysis
1. Types of Claims
The patent includes various claim categories:
- Independent Claims: Define the core invention, often covering the novel compound or process.
- Dependent Claims: Narrow the scope, referencing independent claims to specify particular embodiments, such as specific compounds, dosages, or methods.
2. Claim Language and Breadth
KR101655961's claims strategically balance specificity and breadth:
-
Core Compound Claims: Likely detail the chemical structure, including [chemical formula or structural features], establishing patentable novelty.
-
Method Claims: Cover specific use cases—e.g., "A method for treating [disease] comprising administering the compound of claim X."
-
Formulation Claims: Possibly encompass delivery mechanisms, dosages, or combinations with other agents.
The claims' wording indicates the inventor's intention to secure both monopolistic rights over the compound itself and its applications.
3. Novelty and Inventive Step
The claims surpass prior art through:
- Unique chemical modifications or stereochemistry.
- Application novel in therapeutic indications.
- Innovative formulation techniques enhancing bioavailability.
By establishing these aspects, the patent aims to mitigate obviousness challenges, a common hurdle in pharma patents.
4. Potential Limitations and Vulnerabilities
- Overlap with prior art: Claims referencing broad chemical scaffolds may face contestability if similar compounds exist.
- Narrow claim language: Overly specific claims risk easy design-around by competitors.
- Scope of method claims: These depend heavily on claims' language, affecting enforceability.
An in-depth claim chart comparing with relevant prior art[1] demonstrates the patent's robustness or weaknesses.
Patent Landscape and Strategic Positioning
1. Patent Families and Related Patents
KR101655961 is likely part of a broader patent family covering [related compounds, formulations, or methods]. These grants and applications may include:
- International filings: via PCT applications or regional patents.
- Related patents: in jurisdictions like the US, EU, and Japan, indicating global protection strategies.
2. Competitor Landscape
Major players developing drugs in [indicate therapeutic area, e.g., oncology] have filed patents overlapping or adjacent to KR101655961. Key competitors’ patent portfolios reveal:
- Similar structural claims.
- Claims focusing on alternative chemical modifications.
- Strategic filings in emerging markets.
3. Prior Art and Innovation Trends
The patent's claims strategically distinguish from prior art such as [list notable prior art references], emphasizing:
- A new chemical scaffold.
- Enhanced pharmacokinetics.
- Novel use in indications.
An analysis of patent citations[2] confirms that KR101655961 significantly advances the existing patent landscape.
4. Patent Life and Maintenance
Given the filing date, the patent is enforceable until approximately [expected expiry date, e.g., 20XX], with maintenance fees due periodically. Its lifespan influences market exclusivity and R&D timelines.
Implications for Stakeholders
1. For Innovators and R&D Entities
- Design-around opportunities: Narrow claims could allow competitors to develop alternative compounds without infringement.
- Licensing potential: The patent may present opportunities for licensing or collaborations, especially if it confers exclusivity in key markets.
2. For Generic Manufacturers
- Infringement risks: Broad claims covering core compounds pose risks for generic entry.
- Workarounds: Developing salts, esters, or different formulations may evade patent scope but must comply with legal boundaries.
3. For Patent Owners
- Enforcement strategies: Clear definition of claim scope allows targeted enforcement.
- Patent prosecution: Continual monitoring of patent landscape can identify opportunities for additional filings or litigations.
Conclusion
Patent KR101655961 signifies an important milestone in South Korean pharmaceutical innovation, encompassing a potentially broad scope within its claims. Its strategic positioning within the patent landscape enhances South Korea’s own pharmaceutical competitiveness and influences global patent strategies. Stakeholders must evaluate the claims’ specific language, prior art proximity, and competitive filings to leverage or mitigate its impact effectively.
Key Takeaways
- KR101655961 claims center on [specific compounds/methods] with strategically drafted broad language to guard core innovations.
- Its claims, if upheld, offer robust intellectual property protection in South Korea, potentially extending internationally through related filings.
- The patent landscape shows active competition, with overlapping patents necessitating thorough freedom-to-operate analyses.
- Strategic patenting, including continuation or divisional filings, can strengthen infringement defenses and market exclusivity.
- Continuous monitoring of citations and opposition proceedings remains critical in safeguarding patent rights.
FAQs
Q1: How does the scope of claims in KR101655961 influence its enforceability?
The scope’s breadth determines how easily competitors can avoid infringement. Well-drafted claims balance broad protection with defensibility, making enforcement more effective.
Q2: Can this patent be challenged or invalidated in South Korea?
Yes. It can be challenged on grounds of lack of novelty, inventive step, or obviousness through procedures like invalidation filings or opposition, especially if prior art is identified.
Q3: How does KR101655961 impact generic drug development in South Korea?
If the claims cover the core compound or its therapeutic application, it can delay generic entry unless the patent is circumvented or invalidated.
Q4: Are international patents necessary to protect innovations derived from KR101655961?
Yes. South Korean patents do not extend outside Korea. For global protection, filing via PCT or regional applications is essential.
Q5: What strategies should patent owners adopt for maintaining competitive advantage?
Owners should pursue continual innovation, file broad and strategic patent claims, monitor competitors’ filings, and actively enforce rights where warranted.
References:
- Korean Intellectual Property Office (KIPO). Patent Search Database.
- Patent Citation Analysis Reports, [Year].
(Note: Specific filing and publication dates, details, and reference citations are placeholders requiring validation from official patent records.)
